Randomised controlled assessor- blind trial to compare the efficacy of tofacitinib v/s methotrexate in patients with moderate to severe atopic dermatitis.
Phase 2
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2024/02/062367
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients >2 years of age with moderate to severe atopic dermatitis (SCORAD >25)
Exclusion Criteria
1.Patients with latent and active tuberculosis.
2.Patients receiving systemic immunosuppressive therapy in last 1 month.
3.Patients unable to come for follow up.
4.History of immunization with live vaccines in last 4 weeks.
5.Pregnant and lactating females.
6.Patients with history of thromboembolic phenomenon or on anti-coagulants.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method